JP2023502251A5 - - Google Patents
Info
- Publication number
- JP2023502251A5 JP2023502251A5 JP2022529287A JP2022529287A JP2023502251A5 JP 2023502251 A5 JP2023502251 A5 JP 2023502251A5 JP 2022529287 A JP2022529287 A JP 2022529287A JP 2022529287 A JP2022529287 A JP 2022529287A JP 2023502251 A5 JP2023502251 A5 JP 2023502251A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- administration
- subject
- approximately
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962937964P | 2019-11-20 | 2019-11-20 | |
| US62/937,964 | 2019-11-20 | ||
| PCT/US2020/061257 WO2021102124A1 (en) | 2019-11-20 | 2020-11-19 | Methods of inducing or enhancing farnesoid x receptor (fxr)-mediated transcriptional response |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023502251A JP2023502251A (ja) | 2023-01-23 |
| JP2023502251A5 true JP2023502251A5 (https=) | 2023-11-09 |
Family
ID=75981072
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022529287A Pending JP2023502251A (ja) | 2019-11-20 | 2020-11-19 | ファルネソイドｘ受容体（ｆｘｒ）を介した転写応答を誘導または促進する方法 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20220409631A1 (https=) |
| EP (1) | EP4061377A4 (https=) |
| JP (1) | JP2023502251A (https=) |
| KR (1) | KR20220119367A (https=) |
| CN (1) | CN114786678A (https=) |
| TW (1) | TW202128200A (https=) |
| WO (1) | WO2021102124A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI819307B (zh) * | 2020-05-19 | 2023-10-21 | 吉亞生物科技股份有限公司 | 萜類化合物在治療或預防纖維化疾病中的用途 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9713605B2 (en) * | 2011-11-18 | 2017-07-25 | Simpson Biotech Co., Ltd. | Ameliorative or preventive effect of Antrodia cinnamomea in arthritis, cartilage destruction, or chondrocyte death |
| CN103159732A (zh) * | 2011-12-15 | 2013-06-19 | 台湾利得生物科技股份有限公司 | 一种聚乙炔化合物、含其中的萃取物及其应用 |
| JP2014139153A (ja) * | 2012-08-24 | 2014-07-31 | Taiwan Antitumer Biotech Co Ltd | 腫瘍の治療及び／又は予防における抗がん薬と組み合わせたアントシン誘導体 |
| WO2015065983A1 (en) * | 2013-10-29 | 2015-05-07 | Lumena Pharmaceuticals, Inc. | Bile acid recycling inhibitors for treatment of gastrointestinal infections |
| CN104606260B (zh) * | 2014-12-25 | 2018-01-30 | 恩扬生物科技股份有限公司 | 牛樟芝子实体萃取物用于改善化疗副作用的用途 |
| TWI623749B (zh) * | 2015-04-30 | 2018-05-11 | 吳永昌 | 一種樟芝萃取物製備及分析方法 |
| CN105311036B (zh) * | 2015-11-26 | 2017-11-21 | 中国农业大学 | 樟芝酸h在防治药物性肝损伤中的应用 |
-
2020
- 2020-11-19 TW TW109140455A patent/TW202128200A/zh unknown
- 2020-11-19 KR KR1020227017124A patent/KR20220119367A/ko active Pending
- 2020-11-19 WO PCT/US2020/061257 patent/WO2021102124A1/en not_active Ceased
- 2020-11-19 EP EP20890835.0A patent/EP4061377A4/en active Pending
- 2020-11-19 CN CN202080078165.4A patent/CN114786678A/zh active Pending
- 2020-11-19 US US17/776,922 patent/US20220409631A1/en active Pending
- 2020-11-19 JP JP2022529287A patent/JP2023502251A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023002662A5 (https=) | ||
| ES2640787T3 (es) | Combinación de un derivado de rapamicina y letrozol para tratar el cáncer de mama | |
| US20220000824A1 (en) | Treatment of pulmonary arterial hypertension using therapeutically effective oral doses of 10-nitro-9(e)-octadec-9-enoic acid | |
| JP2012529486A5 (https=) | ||
| US20230141609A1 (en) | Methods of Treating Amyotrophic Lateral Sclerosis and Symptoms | |
| JP2009533457A (ja) | Ｃ−ニトロソから誘導されるニトロキシル供与体 | |
| DE69718347T2 (de) | VERWENDUNG EINER ZUSAMMENSETZUNG AUS H+, K+ -ATPase-INHIBITOREN UND GLUCOCORTIKOIDEN ZUR BEHANDLUNG VON NASENPOLYPEN | |
| JP2020504129A (ja) | 非アルコール性脂肪性肝炎（ｎａｓｈ）および肝線維症のための併用療法 | |
| JP2021502392A5 (https=) | ||
| JP2005519893A5 (https=) | ||
| CN112292125B (zh) | 蛋白尿的治疗 | |
| JP2023502251A5 (https=) | ||
| WO2019053582A1 (en) | COMBINATIONS HAVING FXR AGONISTS | |
| US8372824B2 (en) | GABA-steroid antagonists and their use for the treatment of CNS disorders | |
| JP2023553253A5 (https=) | ||
| EP3512514A1 (en) | Novel regimes of fxr agonists | |
| JP2019507786A5 (https=) | ||
| TW201811372A (zh) | 利用fxr促效劑之方法 | |
| JPS59199630A (ja) | 卵巣機能低下症治療剤 | |
| US11628163B2 (en) | 1-piperidinepropionic acid for treating a fibrosing disease | |
| JP2019509309A5 (https=) | ||
| RU2017140078A (ru) | Косметический способ и его терапевтическое применение для уменьшения объема жировой ткани | |
| JP2022544463A5 (https=) | ||
| JP2018507880A5 (https=) | ||
| JP2022552199A5 (https=) |